Browsing by Author "Bastos, Renata Chagas"
Now showing items 1-20 of 29
-
Amino acid analysis by LC-MS/MS using precolumn derivatization with aTRAQ™ reagent: a preliminary study
Bastos, Renata Chagas et al. | Date Issued: 2016 -
Brazilian meningococcal C conjugate vaccine: scaling up studies
Bastos, Renata Chagas et al. | Date Issued: 2013 -
Cell penetrating peptides functionalization in polymeric nanoparticles containing antiviral as a strategy for the Neurocovid treatment
Premazzi, Melissa Chamon Alves et al. | Date Issued: 2021 -
Cost Comparison: from pilot to large scale manufacturing of the Brazilian Meningococcal C conjugate vaccine
Bastos, Renata Chagas et al. | Date Issued: 2014 -
Could antibodies be stable and effective after years of storage?
Vidal, Luãnna Elisa Liebscher et al. | Date Issued: 2022 -
Desenvolvimento de estratégia de purificação de Imunoglobulina M
Nascimento, Hilton Jorge et al. | Date Issued: 2017 -
Desenvolvimento de estratégias para o aperfeiçoamento da produção do conjugado Anti-IgG Canina/Peroxidase utilizado no Kit EIE/LVC
Mendes, Edinéa Pastro et al. | Date Issued: 2014 -
Determination of hydrazine in a meningococcal C conjugate vaccine intermediary product
Bastos, Renata Chagas et al. | Date Issued: 2010 -
Development of a Meningococcal W Conjugate Vaccine
Souza, Iaralice Medeiros de et al. | Date Issued: 2019 -
Development of a therapeutic strategy for COVID-19 based on angiotensin-converting enzyme 2 (ACE-2) recombinant proteins
Madeira, Luciana da Silva et al. | Date Issued: 2022 -
Development of monoclonal antibodies targeting SARS-CoV-2 Spike and Nucleocapsid proteins
Carvalho, Milena Mouta Verdan França et al. | Date Issued: 2021 -
Escalonamento da produção de uma nova vacina menigocócica C conjugada
Bastos, Renata Chagas | Date Issued: 2016Neisseria meningitidis é um dos agentes patogênicos associados a casos de meningite e outras manifestações clínicas em todo o mundo. Atualmente, no quadro epidemiológico brasileiro, 60% dos casos notificados de doença ... -
Evaluation of Scheduled MRM parameters: a powerful tool for analysis of modified carrier protein of meningococcal polysaccharide C conjugate vaccine
Corrêa, Marilza Batista et al. | Date Issued: 2016 -
Expression, purification and characterization of S542-931 and RBD330-524 from spike protein of SARS-Cov-2
Argondizzo, Ana Paula Corrêa et al. | Date Issued: 2021 -
Expression, purification and characterization of the SARS-CoV-2 nucleocapsid antigen
Silva Junior, Haroldo Cid da et al. | Date Issued: 2021 -
Initial assays for the characterization of a biosimilar anti-PD-1 monoclonal antibody to Nivolumab
Ramos, Michael Bernardes et al. | Date Issued: 2019 -
LC-MS/MS as a tool for analysis of underivatized glutamic and aspartic amino acids residues from tetanus toxoid
Corrêa, Marilza Batista et al. | Date Issued: 2015 -
Macromolecule Laboratory (LAMAM): evaluation of 10 years of experience to face a new challenge
Nascimento, Hilton Jorge et al. | Date Issued: 2019 -
Molecular characterization of tetanus toxoid used in conjugate vaccines produced by Bio-Manguinhos - FIOCRUZ
Corrêa, Izabella Buty da Silva et al. | Date Issued: 2018 -
New approaches for recombinant protein VP1-2A of HAV production and characterization based on liquid microarray assay: application for developing a point-of care diagnostic test
Sucupira, Michel Vergne Felix et al. | Date Issued: 2022